Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | ||||||
{[ item.p_purity ]} | {[ item.pr_size ]} | Inquiry |
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price) ]} |
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price) ]} | {[ item.pr_usastock ]} | in stock Inquiry - | {[ item.pr_chinastock ]} | {[ item.pr_remark ]} in stock Inquiry - | Login | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
CAS No. : | 2133-34-8 | MDL No. : | MFCD00005166 |
Formula : | C4H7NO2 | Boiling Point : | No data available |
Linear Structure Formula : | NHCH(CH2)2COOH | InChI Key : | - |
M.W : | 101.10 | Pubchem ID : | - |
Synonyms : |
|
Chemical Name : | (S)-Azetidine-2-carboxylic acid |
Signal Word: | Warning | Class: | |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With thionyl chloride; at 20℃; for 3h; | SYNTHETIC EXAMPLES; Example 1; Synthesis of (S)-1-[(R)-7-(3,5-Dichloro-phenyl)-5-methyl-6-oxo-5-(4-pyrimidin-5-yl-benzyl)-6,7-dihydro-5H-imidazo[1,2-a]imidazole-3-sulfonyl]-azetidine-2-carboxylic acid; Thionyl chloride (0.144 mL) was added to a solution of (S)-(-)-2-azetidinecarboxylic acid (0.1 g, 0.99 mmol) in CH3OH (4 mL) and stirred at room temperature for 3 h. The volatiles were removed in vacuo to afford 0.180 g of the desired (s)-(-)-azetidine carboxylic acid methyl ester hydrochloride, which was used without further purification. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
100% | Example 15 (S)-1-(tert-Butoxycarbonyl)azetidine-2-carboxylic Acid (13). To a solution of (S)-2-azetidinecarboxylic acid 12 (1.0 g, 10.0 mmol) and di-tert-butyl dicarbonate (2.83 g, 12.5 mmol) in ethanol (20 mL) and water (10 mL) was added NaOH (420 mg, 10.5 mmol) at 0 C. The mixture was stirred overnight at ambient temperature. After evaporation of the ethanol, water (20 mL) was added, then acidified with diluted HCl to a pH of 3 and extracted with ethyl acetate (50 mL*3). The combined ethyl acetate was washed with water (30 mL) and saturated NaCl (30 mL), and dried over Na2 SO4. After evaporation of the ethyl acetate to afford 1.98 g (100%) of 13 as a white solid. 1H NMR (300 MHz, CDCl3) delta 4.79 (m, 1H), 3.93 (m, 2H), 2.46 (m, 2H), 1.48 (s, 9H). | |
With tetramethyl ammoniumhydroxide; In acetonitrile; at 25℃; for 77h; | (a) (S)-1-(tert-Butyloxycarbonyl)azetidine-2-carboxylic acid.; A mixture of <strong>[2133-34-8]L-azetidine-2-carboxylic acid</strong> (1.0 g, 9.9 mmol, Toronto Research), tetramethylammonium hydroxide pentahydrate (2.0 g, 11 mmol, Aldrich) and di-tert-butyl dicarbonate (3.2 g, 15 mmol, Aldrich) in acetonitrile (50 mL) was stirred for 3 d at 25 C. Additional amount of di-tert-butyl dicarbonate (1.0 g, 4.6 mmol) was added and the mixture was stirred for 5 h at 25 C. The reaction mixture was evaporated under reduced pressure and the residue was partitioned between aqueous solution of K2CO3 and 1:1 mixture of EtOAc/hexane. The aqueous phase was separated, acidified with aqueous solution of citric acid, and extracted with EtOAc (3×). The combined extracts were washed with brine, dried over Na2SO4, filtered and evaporated under reduced pressure. The residue was dried under vacuo to afford the title compound as a white solid. MS (ESI, neg. ion.) m/z: 200 (M-1). | |
With 4-methyl-morpholine; sodium hydrogencarbonate; In 1,4-dioxane; water; | 7a. 1-t-butyloxycarbonyl-2-(S)-azetidinecarboxylic acid To an ice cooled solution of 2-(S)-azetidinecarboxylic acid (10.15 g, 100.39 mmol) in 1,4 dioxane:water (300 mL, 1:1) was added di-tert-butyl dicarbonate (28.48 g, 130.51 mmol), followed by 4-methylmorpholine (11.68 g, 115.45 mmol). The reaction mixture continued to stir 18 hours, gradually warming to room temperature. The reaction mixture was then poured into a ice cooled saturated solution of sodium bicarbonate (250 mL) and washed with ethyl acetate (3*250 ml). The aqueous was then acidified with potassium hydrogen sulfate (pH=1) and the product extracted with ethyl acetate (3*300 ml). These extracts were then dried (Na2 SO4), filtered and concentrated in vacuo. The resulting semisolid was carried forward without further purification. MS (DCI/NH3) m/e 202 (M+H)+, 219 (M+NH4)+. 1 H NMR (CDCl3, 300 MHz) delta: 10.0 (br s, 1H), 4.81-4.76 (t, J=15 Hz, 1H), 3.99-3.83 (m, 2H), 2.62-2.38 (m, 2H), 1.48 (s, 9H). |
To a mixture of (S)-(-)-2-azetidinecarboxylic acid (110 mg, 1.1 mmol), Boc2O (290 mg, 1.30 mmol), and DMAP (0.017 g, 0.14 mmol) in 4:1 DMF/H2O (10 mL) is added Et3N (0.30 mL, 2.2 mmol). The reaction mixture is stirred at rt for 68 h, and then is concentrated. The concentrate is diluted with EtOAc, and the EtOAc solution is washed with cold 10% KHSO4. The combined organic extracts are dried, filtered and concentrated to give the title compound as a colorless oil: TLC (750:250:1 Hexanes/acetone/HCO2H) Rf=0.26; 1H NMR (CD3OD) delta 4.97 (1H), 4.57 (1H), 3.98 (1H), 3.87 (1H), 2.57 (H), 2.13 (1H), 1.42 (9H); MS (-ESI) m/z 200.3. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
90.2% | With sodium hydroxide; In water; at 0 - 20℃; | To a mixture of (5)-azetidine-2-carboxylic acid (1.0 g, 9.89 mmol) in aqueous NaOH solution (2.5 mL, 10 mmol, 4M) was added aqueous sodium hydroxide solution (3.0 mL, 12 mmol, 4 M) drop-wise at 0C, followed by drop-wise addition of benzylcarbonochloridate (1.53 mL, 10.88 mmol). After the addition was complete, the reaction was stirred at room temperature overnight. The reaction mixture was then washed with diethyl ether (30 mL), and the water layer was acidified with dilute hydrochloric acid (1M). The water layer was then extracted with ethyl acetate (30 mL x 3), and the combined ethyl acetate extracts were dried over Na2SO4, filtered and concentrated to give (S)-1-((benzyloxy)carbonyl)azetidine-2-carboxylic acid (2.1 g, 90.2% yield) as a colorless oil. LC-MS: m/z = 236 [M+Hf?, ee> 99% (CHIRALPAK AS-H, 15% ethanol / hexane). |
53% | To a solution of <strong>[2133-34-8]L-azetidine-2-carboxylic acid</strong> (101.1 mg, 1 mmol) in 2N aqueousNaOH (0.675 ml) is added benzylchloroformiate (169 ul, 204.7 mg, 1.2 eq.) and theresulting mixture is stirred at rt for 2 h. The aqueous phase is washed once with EtiO.The aqueous solution is set to pH=2 with a concentrated aqueous HCI solution and thensaturated with solid Na2SO4. It is extracted three times with AcOEt. The combinedorganic phase is dried over Na2SO4. The solvents are evaporated under a stream of airand the crude oil dried under high vacuum overnight, yielding the title compound (126mg) in 53% as a colourless oil: fa = 0.76 min (LC-3), ESI-MS (pos.): m/z 277.16[M+Naf; ^-NMR (CDC13): 5 (ppm) 2.53 (bs, 2H, C^CHaN), 4.01 (t, 2H, CJJbN),4.82 (t, 1 H, CHC02H), 5.15 (s, 2H, OCtfcPh), 7.35 (s, 5 H, Harom.). | |
In water; N,N-dimethyl-formamide; at 0 - 20℃; | Example 301 (S)-2-[4-(4-Cyclopropylcarbamoyl-phenyl)-thiazol-2-ylcarbamoyl]-azetidine-1-carboxylic acid benzyl ester (Compound 5301) (S)-Azetidine-1,2-dicarboxylic acid 1-benzyl ester (S)-Azetidine-2-carboxylic acid (250.4 mg, 2.5 mmol) was dissolved in DMF (15 mL) and distilled water (6 mL). The solution was cooled to 0 C., and DIEA (645 muL, 3.7 mmol) was added followed by benzyl chloroformate (530 muL, 3.7 mmol). The reaction was stirred at 0 C. and allowed to warm to ambient temperature overnight. The reaction was filtered and purified by reverse phase HPLC to give the desired product. |
A649811[ 2133-35-9 ]
(S)-Azetidine-2-carboxylic acid hydrochloride
Reason: Free-salt
[ 7729-30-8 ]
(R)-Azetidine-2-carboxylic acid
Similarity: 1.00
[ 647854-72-6 ]
(R)-Azetidine-2-carboxylic acid hydrochloride
Similarity: 0.97
[ 99571-58-1 ]
6-Methylpiperidine-2-carboxylic acid
Similarity: 0.89
[ 2133-33-7 ]
(S)-Piperidine-2-carboxylic acid hydrochloride
Similarity: 0.87
[ 7729-30-8 ]
(R)-Azetidine-2-carboxylic acid
Similarity: 1.00
[ 647854-72-6 ]
(R)-Azetidine-2-carboxylic acid hydrochloride
Similarity: 0.97
[ 99571-58-1 ]
6-Methylpiperidine-2-carboxylic acid
Similarity: 0.89
[ 2133-33-7 ]
(S)-Piperidine-2-carboxylic acid hydrochloride
Similarity: 0.87
[ 7729-30-8 ]
(R)-Azetidine-2-carboxylic acid
Similarity: 1.00
[ 647854-72-6 ]
(R)-Azetidine-2-carboxylic acid hydrochloride
Similarity: 0.97
[ 98019-65-9 ]
4-Oxo-2-azetidinecarboxylic acid
Similarity: 0.85
[ 162698-26-2 ]
Methyl azetidine-2-carboxylate hydrochloride
Similarity: 0.83